Cellectar Biosciences, Inc. 8-K

What Happened
Cellectar Biosciences, Inc. (CLRB) announced its financial results for the quarter ended March 31, 2026, in a press release dated May 14, 2026. The company furnished that press release as Exhibit 99.1 to Form 8-K (Item 2.02) and incorporated it by reference. The filing also includes the company’s Inline XBRL cover page data (Exhibit 101).

Key Details

• Form 8-K filed May 14, 2026, reporting quarterly results for the period ended March 31, 2026 (Item 2.02).
• Press release titled “Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates” furnished as Exhibit 99.1.
• Interactive XBRL cover page data included in Exhibit 101 (Inline XBRL).

Why It Matters
This filing signals that Cellectar has released its latest quarterly earnings and any related corporate updates. Retail investors should read the attached press release and the company’s subsequent filings to see reported revenue, expenses, cash position, and any operational or clinical updates that could affect the stock. The 8-K itself indexes the release and machine-readable cover page data but does not present detailed financials in the Form 8-K text—those details are in the furnished press release and related filings.